References
- Otani H, Tanaka H, Inoue T, Umemoto M, Omoto K, Tanaka K, Sato T, Osako T, Masuda A, Nanoyama A, Kagawa T. In vitro study on contribution of oxidative metabolism of isolated rabbit heart mitocondria to myocardial reperfusion injury. Circ Res 1984; 55: 168–75
- Otani H, Omoto K, Tanaka H, Sato T, Umemoyo M, Tatsumi A, Saito Y, Osako T, Fukunako M, Kashara K, Masuda A, Nanoyama A, Kogawa T. Reperfusion injury induced by augmented oxygen uptake in the initial reperfusion period. Possible efficacy of extreme hemodilution. J Moll Cell Cardiol 1985; 17: 457–65
- Johansen J, Chiantella V, Faust K, Johnston W, McCain B, Hartman M, Mills S, Hester O. Cardell R: Myocardial protection with blood cardioplegia in ischemically injured hearts. Reduction of reoxygenation injury with allopurinol. Ann Thorac Surg 1988; 45: 319–26
- Stewart J R., Crute S L., Loughlin V, Hess M L., Greenfield M S. Prevention of free radical-induced myocardial reperfusion injury with allopurinol. J Thorac Cardiovasc Surg 1985; 90: 68–73
- Menasche P, Grusset C, Gauduel Y. Enhancement of cardioplegic protection with the free-radical scavenger peroxidase. Circulation 1986; 74(supp 3)138–44
- McCord J M., Fridovich I. The biology and pathology of oxygen radicals. Ann Intern Med 1978; 89: 122–7
- Jolly S R., Kane W J., Bailie M B., Abrams G D., Lucchesi B R. Canine myocardial reperfusion injury Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 1984; 54: 277–81
- Maerson F Z., Kagan V E., Kozlov Y P., Belkina L M., Arkhipenko Y V. The role of lipid preoxidation in pathogenesis of ischemic damage and antioxidant protection of the heart. Bas Res Cardiol 1982; 77: 465–71
- Rao R S., Mueller H S. Lipid peroxidation and acute myocardial ischemia. Myocardial injury, J J. Spitzer. Plenum Press, New York 1983; 341
- McCord J M. Oxygen-derived free radicals in postischemic tissue injury. N Eng J Med 1985; 312: 159–65
- Elion G B., Konvesky A, Hitchings G H. Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. Biochem Pharmacol 1966; 15: 863–80
- Myers C L., Weiss S J., Kirsh M M., Shepard B H., Shlafer M. Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase. allopurinol or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts. J Thorac Cardiovasc Surg 1986; 91: 281–9
- Chambers D J., Braimbridge M V., Hearse D J. Free radicals and cardioplegia: allopurinol and oxypurinol reduce myocardial injury following ischemic arrest. Ann Thorac Surg 1987; 44: 291–7
- Tabayashi K, Suzuki Y, Nagamine S, Ito Y, Sekin Y, Mohri H. A clinical trial of allopurinol (zyloric) for myocardial protection. J Thorac Cardiovasc Surg 1991; 101: 713–8
- Otani H, Engelman R M., Rousou J A., Breyer R H., Lemeshow S, Das D K. Cardiac performance during reperfusion improved by pretreatment with oxygen free-radical scavengers. J Thorac Cardiovasc Surg 1986; 91: 290–5